期刊文献+

某三甲医院降糖药的药物利用分析 被引量:3

Utilization analysis of prescriptions of hypoglycemic agents
下载PDF
导出
摘要 目的了解安徽省某三甲医院在新医改模式下降糖药的应用情况及趋势。方法采用处方资料的回顾性研究方法,以药物使用构成比、金额排序与序号比值为评价指标对安徽省某三甲医院2010年5—8月及2011年5—8月降糖药的药物利用情况进行统计、分析。结果降糖药消耗金额增加,其中胰岛素连续两年的消耗金额排序均为第1位;用药频度(DDDs)排序前3的分别是胰岛素、二甲双胍、阿卡波糖。结论各类降糖药的序号比值接近1,从药物利用分析的角度,提示降糖药的应用基本合理。在该研究阶段,新医改的药物政策尚未对三级医院中该类药物的使用产生显著影响。 Objective To analyze the utilization and the trend of hypoglycemic agents in one of Grade ⅢA hospital under the new mode of medical reform.Methods Retrospective analysis was made of the prescribing information.With drug use constituent ratio,the ratio of the amount of sorting and serial number as evaluation indexes hypoglycemic drug utilization statistics and analysis were made in a hospital in Anhui Province from May to August of 2010 and from May to August of 2011.Results The amount of diabetes drug consumed increased by season,with insulin ranking the first.The top three in DDDs were insulin,metformin,and acarbose.Conclusions The application of hospital medicine is basically reasonable.The serial number ratio of all kinds of hypoglycemic agents is close to 1,suggesting that the use of hypoglycemic agents is reasonable.During the research phase,the drug policy of the new health care reform has not been a significant impact on the use of these drugs in the tertiary hospitals.
出处 《安徽医药》 CAS 2013年第8期1421-1423,共3页 Anhui Medical and Pharmaceutical Journal
基金 安徽省自然科学基金项目(No1208085QH153) 安徽省软科学研究计划项目(No11020503050)
关键词 降糖药 药物利用 合理用药 限定日剂量 hypoglycemic agents drug utilization rational use of drugs defined daily dose
  • 相关文献

参考文献8

  • 1刘亚松,章红.新诊断2型糖尿病早期胰岛素强化治疗的临床观察[J].安徽医药,2009,13(10):1265-1266. 被引量:6
  • 2王淑芳,郭玉秀.早期胰岛素治疗对2型糖尿病患者并发症发生率和治疗费用的影响[J].中国当代医药,2012,19(4):43-44. 被引量:5
  • 3K(o)nig M,Holzhütter HG.Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy[J].J Biol Chem,2012,287(44):36978-36989.
  • 4Williams SA,Shi L.The burden of hypoglycemia on healthcare utilization,costs,and quality of life among type 2 diabetes mellitus patients[J].J Diabetes Complications,2012,26(5):399-406.
  • 5陆益,张桂芬,朱爱国,等.2007-2010年苏州大学附属常熟医院中药注射剂应用分析[J].中国医院用药与分析,2011,11(6):498-501.
  • 6周琳.口服降糖药的临床应用分析[J].北方药学,2012,9(6):90-91. 被引量:4
  • 7Mori RC,Hirabara SM.Glimepiride as insulin sensitizer:increased liver and muscle responses to insulin[J].Diabetes Obes Metab,2008,10(7):596-600.
  • 8Marks DH.Drug utilization,safety and clinical use of Actos and Avandia[J].Int J Risk Saf Med,2013,25(1):39-51.

二级参考文献22

  • 1李光伟.对2型糖尿病β细胞功能衰竭和胰岛素治疗的思考——给2型糖尿病病人一个更为美好的未来[J].国外医学(内分泌学分册),2004,24(4):271-273. 被引量:52
  • 2尹春茹,刘红,李志民,林军宁,程娜.初诊2型糖尿病短期胰岛素强化治疗疗效观察[J].临床荟萃,2007,22(12):884-886. 被引量:4
  • 3Haffner SM, Mykkanen L, Festa A, et al. Insulin-resistant precliabetic subjects have more aterogenic risk factors than insulin-sensitire prediabetic subjects[ J]. Circulation ,2000,101 ( 3 ) : 975 - 80.
  • 4Bonora E, Targher G, Alberiche M, et al. Homeastasis model assessment closely, mims the glucose clamp tethnigue in the assessment of insulin sensitivity:studies in subjects with various degree of glucose tolerance and insulin sensitivily [ J ]. Diabetes Care, 2000,23 ( 1 ) : 57.
  • 5Leahy JL. Pathogenesis of type 2 diabetesmellitus [ J ]. ArchMed Res,2005, 36(3) : 197 -209.
  • 6Purrello FRabuazza AM. Metabolic factors that affect beta cell function and surviva [ J ]. ldiabet Nuts Metab,2000,1 (3) : 84 - 91.
  • 7Dailey GE. 3rd Early insulin:an important therapeutic strategy [ J]. Diabetes Care, 2005, 28( 1 ) :220 - 1.
  • 8World Health Organization.The World Health Report[R]. Geneva :WHO, 1998.
  • 9InternationalDiabetesFederatio.DiabetesAtlaslS].2thed.Brussels.2003.
  • 10Wild S, Roglic G,Green A ,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2003 [J]. Diabetes Care,2004,27 (10) : 1047-1053.

共引文献12

同被引文献28

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部